Paul TheisenPatient Acquisition
Amy GilesIncreasing Engagement
Matt TurnerPatient Affordability
Stacey GandlerBrand Nourishment
Frank BurrellScientific Storytelling
Daniel SontupeMarket Access
Bud BilanichSuccess Coach
Suma Ramadas, PhDMedical Affairs
Brenda SnowAuthentic Patient Voice
Matthew DurhamOmnidynamic Marketing
Liz KaneImpactful Strategy
Joey CohenMedication Adherence
Pat PurcellMeeting Engagement
David LinetskyPoint-of-Care Marketing
Phase 1 Study of PARP Inhibitor 2X-121 Selected as Oral Presentation June 1, 2018HOERSHOLM, ...
SOUTH SAN FRANCISCO, Calif., May 25, 2017 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email